Using proprietary RecombiPure (RP) protein expression technology, Antoxerene is able to recombinantly express hard or impossible to manufacture protein targets in a full-length, biologically active form. The basis of this technology is a combination solubility/affinity tag derived from a thermophile. Due to its thermophilic origin, the tag is stable, inexpensive, small, and possesses antibody level binding affinities.
High throughput screening assays are developed, validated and scaled on liquid handling robotics systems using state-of-the-art microplate technologies. Using these screens, staff scientists can identify lead compounds that disrupt molecular pathways implicated in disease onset and progression.